期刊文献+

美罗培南治疗儿童重症细菌感染的评价 被引量:17

原文传递
导出
摘要 目的探讨美罗培南对于儿童重症细菌性感染的疗效及安全性。方法选择2005年1月至2006年3月在上海儿童医学中心住院治疗的2个月至12岁重症细菌感染儿童120例,静脉应用美罗培南,评价临床治疗效果。结果应用美罗培南的120例患儿疗效优良。结论美罗培南对于儿童重症细菌感染的疗效显著,安全性高。
出处 《中国实用儿科杂志》 CSCD 北大核心 2008年第2期139-140,共2页 Chinese Journal of Practical Pediatrics
作者简介 E-mail:luyi61luyi@sohu.com
  • 相关文献

参考文献6

  • 1周绪华,梁新亮,李轶,周在咸.临床常见病原菌分布及耐药性分析[J].实用诊断与治疗杂志,2004,18(2):120-121. 被引量:151
  • 2张婴元,徐艳,吴菊芳,花天放,周柱,颜式可,郑丽叶,吴卫红,汪复.美罗培南的临床评价[J].中国抗感染化疗杂志,2001,1(3):137-141. 被引量:28
  • 3中华医学会儿科学会急救学组.第四届全国小儿急救医学研讨会纪要[J].中华儿科杂志,1995,33:370-370.
  • 4Jaimovich DG, Hauser GGJ, Witte MK, et al. Guidelines for developing admission and discharge policies for the pediatric intensive care unit[J]. Crit Care Med, 1999,27(4):843-845.
  • 5Hurst M, Lamb HM. Meropenem :a review of its use in patients in intensive care units[J]. Drugs,2000,59(3):653-680.
  • 6Pena C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Kleb-siella pneumoniae producing extended spectrumβ-lactamases (ESBL-KP) in the intensive care unit[J]. J Hosp Infect,1997,35:9.

二级参考文献17

  • 1Quale J,Landman D,Saurina G, et al. Manipulation of a hospital antimicrobial fomnulary to control an outbreak of vancomycin resistant enterococci. Clin Infect Dis, 1996,23 : 1020.
  • 2Waterer GW, Wunderink RG. Increasing threat of gram-negative bacteria[J]. Crit Care Med, 2001, 29, 4(Suppl): N75-81
  • 3Mathai D, Lewis M T, Kugler KC, et al. Antibacterial activity of 41 antimicrobi als tested against over 2733 bacterial isolates from hospitalized patients with p neumonia: Results from the SENTRY antimicrobial surveillance program[J]. Di agn Microbiol Infect Dis, 2001, 39(2): 105-116
  • 4Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive ca re units[J]. Crit Care Med, 2001, 29, 4(Suppl): N64-68
  • 5Hurst M, Lamb HM. Meropenem: a review of its use in patients in intensive care[J]. Drugs, 2000, 59(3): 653-680
  • 6Norrby SR, Gildon KM. Safety profile of meropenem: a review of nearly 5000 patients treated with meropenem[J]. Scand J Infect Dis, 1999, 31(1): 3-10
  • 7Calandra G, Lydick E, Carrigan J, et al. Factors predisposing to seizures i n seriously ill infected patients receiving antibiotics: experience with imipene m/cilastatin[J]. Am J Med, 1988, 84(5): 911-918
  • 8Wong VK, Wright HT Jr, Ross LA, et al. Imipenem/cilastatin treatment of bacte rial meningitis in children[J]. Pediatr Infect Dis J, 1991, 10(2): 122-125
  • 9Norrby SR. Neurotoxicity of carbapenem antibiotics: consequences for their us e in bacterial meningitis[J]. J Antimicrob Chemother, 2000, 45(1): 5-7
  • 10Klugman KP, Dagan R. Carbapenem treatment of meningitis[J]. Scan J Infec t Dis, 1995, 96(Suppl):45-48

共引文献411

同被引文献110

引证文献17

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部